This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
NewsThe 50 most influential Black, Asian and minority ethnic people in health: The judges
The judges for 2025’s list of healthcare’s 50 most influential Black and minority ethnic leaders
-
NewsThe 50 most influential Black, Asian and minority ethnic people in health: The alumni
Alphabetical by surname: Sponsored by Dame Elizabeth Anionwu, emeritus professor of nursing, University of West London Professor JS Bamrah, former chair, British Association of Physicians of Indian Origin Yvonne Coghill, former director for the Workplace Race Equality Standard implementation, NHS England Jacqueline Dunkley-Bent, former chief midwifery officer, ...
-
NewsThe 50 most influential Black, Asian and minority ethnic people in health: Full list
The top 50 most influential Black, Asian and minority ethnic leaders in English health and care – listed alphabetically
No comments yet